Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Carisma Therapeutics | CARM | Sep 25, 2024 | 0.98 | +0.28 |
Carlisle Companies | CSL | Sep 25, 2024 | 438.13 | -0.08 |
Carlyle Credit Income Fund | CCIF | Sep 25, 2024 | 8.23 | 0.00 |
Carlyle Credit Income Fund | CCIA | Sep 25, 2024 | 25.83 | 0.00 |
Carlyle Secured Lending | CGBD | Sep 25, 2024 | 17.30 | -0.29 |
CarMax | KMX | Sep 25, 2024 | 74.49 | -2.63 |
Carmell | CTCX | Sep 25, 2024 | 0.31 | -3.99 |
Carnival | CCL | Sep 25, 2024 | 18.04 | -3.68 |
Carnival ADR | CUK | Sep 25, 2024 | 16.34 | -4.16 |
CarParts.com | PRTS | Sep 25, 2024 | 0.88 | -5.39 |
Carpenter Technology | CRS | Sep 25, 2024 | 161.78 | +1.16 |
Carriage Services | CSV | Sep 25, 2024 | 32.78 | -0.91 |
Carrier Global | CARR | Sep 25, 2024 | 79.67 | -0.92 |
Cars.com | CARS | Sep 25, 2024 | 17.11 | -2.17 |
Carter Bankshares | CARE | Sep 25, 2024 | 17.38 | -0.11 |
Carters | CRI | Sep 25, 2024 | 66.22 | -1.75 |
Cartesian Growth II A | RENE | Sep 25, 2024 | 11.46 | +0.09 |
Cartesian Growth II Unit | RENEU | Sep 25, 2024 | 11.38 | 0.00 |
Cartesian Therapeutics | RNAC | Sep 25, 2024 | 16.44 | +1.99 |
Cartica Acquisition A | CITE | Sep 25, 2024 | 11.53 | +0.05 |
Carvana | CVNA | Sep 25, 2024 | 169.65 | -1.77 |
Carver Bancorp | CARV | Sep 25, 2024 | 1.95 | +0.78 |
Casella Waste Systems A | CWST | Sep 25, 2024 | 100.01 | -0.12 |
Caseys General Stores | CASY | Sep 25, 2024 | 371.98 | +0.03 |
CASI Pharmaceuticals | CASI | Sep 25, 2024 | 5.27 | -4.36 |
Cass Information Systems | CASS | Sep 25, 2024 | 40.66 | -1.91 |
Cassava Sciences | SAVA | Sep 25, 2024 | 30.47 | +3.01 |
Castellum | CTM | Sep 25, 2024 | 0.17 | -2.46 |
Castle Biosciences | CSTL | Sep 25, 2024 | 28.60 | -2.22 |
Castor Maritime | CTRM | Sep 25, 2024 | 3.95 | -2.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.